Ofloxacin Concentration-toxicity Relationship in the Elderly (ROSCO)
Determination of a Trough Serum Concentration of Ofloxacin Associated to Increase in Side Effects Frequency in Elderly Treated for Bone and Joint Infection
Sponsor: Centre Hospitalier Universitaire, Amiens
Listed as NCT04496024, this NA trial focuses on Adverse Drug Reactions and Bone and Joint Infection and remains actively recruiting participants. Sponsored by Centre Hospitalier Universitaire, Amiens, it has been updated 8 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Jul 2025 — Present [monthly]
Recruiting NA
Status: Unknown → Recruiting
-
Apr 2025 — Jul 2025 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Apr 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Apr 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
▶ Show 3 earlier versions
-
Nov 2022 — Apr 2023 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire, Amiens
For direct contact, visit the study record on ClinicalTrials.gov .